LIXT
LIXTE BIOTECH (LIXT)
NASDAQ
$6.67-$0.04 (-0.66%)
Price as of Jun 03, 2026 5:31 PM EDT
  • $77.4M
    Market Cap
  • 382.73%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
40,000
+339.13%
9,109
-63.56%
25,000
+0.004%
Gross Profit
0
+100.00%
-40,000
+339.13%
-9,109
-63.56%
-25,000
+0.004%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-75,643
-89.58%
-726,232
-19.14%
-898,100
-33.44%
-1.3M
-22.31%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
5.1M
+42.96%
3.6M
-29.81%
5.1M
-19.35%
6.3M
-6.09%
Operating Profit
-5.1M
+42.96%
-3.6M
-29.81%
-5.1M
-19.35%
-6.3M
-6.09%
Interest Income
7,388
+4.82%
7,048
-59.69%
17,486
+56.19%
11,195
+1,688.34%
Interest Expense
-9,158
-45.56%
-16,821
+3.62%
-16,233
+82.91%
-8,875
+19.71%
Interest Income and Expense and Net
-1,770
-81.89%
-9,773
-879.97%
1,253
-45.99%
2,320
+134.18%
Total Nonoperating Income and Expense
3,740
-77.77%
16,821
+3.62%
16,233
+82.91%
8,875
+19.71%
Income before Taxes
-5.1M
+42.96%
-3.6M
-29.81%
-5.1M
-19.35%
-6.3M
-6.09%
Income Taxes
1,600
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-6.1M
N/A
N/A
N/A
-5.1M
-19.41%
-6.3M
-6.18%
Net Income from Continuing Operations Applicable to Common
-6.1M
N/A
N/A
N/A
-5.1M
-19.41%
-6.3M
-6.18%
Basic EPS and Net Income
N/A
N/A
-1.59
-40.23%
-2.66
+565.00%
-0.40
-20.00%
Diluted EPS and Net Income
-1.26
-20.75%
-1.59
-40.23%
-2.66
+565.00%
-0.40
-20.00%
Basic Weighted Average Shares
4.8M
+115.21%
2.2M
+17.41%
1.9M
-87.89%
15.8M
+17.41%
Diluted Weighted Average Shares
4.8M
+115.21%
2.2M
+17.41%
1.9M
-87.89%
15.8M
+17.41%
Balance Sheet
Cash and Cash Equivalents
5.1M
+391.54%
1.0M
-75.28%
4.2M
-21.48%
5.4M
+10.98%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.1M
+391.54%
1.0M
-75.28%
4.2M
-21.48%
5.4M
+10.98%
Total Current Assets
5.2M
+398.42%
1.0M
-75.89%
4.3M
-22.51%
5.6M
+9.16%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
6.6M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
6.6M
+798.60%
732,532
+63.69%
447,512
N/A
N/A
N/A
Total Assets
12.7M
+1,011.62%
1.1M
-73.41%
4.3M
-22.51%
5.6M
+9.16%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
1.3M
+318.84%
318,284
+1.41%
313,858
-20.50%
394,786
+30.32%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
438,959
+770,003.51%
57
0.00%
57
N/A
N/A
N/A
Total Liabilities
1.8M
+456.76%
318,284
+1.41%
313,858
-20.50%
394,786
+30.32%
Retained Earnings
-58.1M
+11.54%
-52.1M
+7.40%
-48.5M
+11.72%
-43.4M
+17.02%
Total Stockholders Equity
9.7M
+1,068.26%
827,219
-79.29%
4.0M
-22.66%
5.2M
+7.83%
Total Shares Outstanding
8.8M
+290.79%
2.2M
0.00%
2.2M
-86.49%
16.6M
+21.10%
Cash Flow
Cash from Operating Activities
-3.1M
-2.97%
-3.2M
-26.29%
-4.3M
-6.91%
-4.6M
+11.32%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-3.2M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.3M
N/A
N/A
N/A
3.1M
-38.86%
5.1M
+31.92%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-87.59%
N/A
N/A
N/A
-103.09%
-13.01%
-118.51%
-9.10%
Return on Equity
-115.88%
N/A
N/A
N/A
-111.07%
-12.41%
-126.81%
-7.63%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.88
+19.00%
3.26
-76.22%
13.73
-2.53%
14.08
-16.24%
Cash Ratio
3.83
+17.36%
3.26
-75.63%
13.39
-1.23%
13.56
-14.84%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow